AA
NEO icon

ALPS Advisors’s NeoGenomics NEO Stock Holding History

ALPS Advisors’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,954
Closed -$287K – 944
2021
Q3 		$287K Sell
5,954
-1,300
-18% -$60.2K ﹤0.01% 867
2021
Q2 		$328K Sell
7,254
-260
-3% -$11.5K ﹤0.01% 777
2021
Q1 		$362K Sell
7,514
-1,813
-19% -$94.4K ﹤0.01% 543
2020
Q4 		$502K Sell
9,327
-5,599
-38% -$253K 0.01% 498
2020
Q3 		$551K Sell
14,926
-1,255
-8% -$46.7K 0.01% 411
2020
Q2 		$501K Sell
16,181
-7,033
-30% -$195K 0.01% 451
2020
Q1 		$641K Buy
+23,214
New +$695K 0.01% 399

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ALPS Advisors's NEO Position: Q4 2021 in Review

ALPS Advisors sold out of NeoGenomics (NEO) in Q4 2021, closing a stake of 5,954 shares — an estimated $287K sold.

ALPS Advisors first reported a position in NEO in Q1 2020 and held it in 7 quarters. The position peaked at $641K in Q1 2020. 307 funds tracked by Wall St. Rank hold NEO as of Q4 2021.

  • ALPS Advisors reported no remaining NeoGenomics position as of Q4 2021 after selling out during the quarter.
  • ALPS Advisors sold 5,954 NeoGenomics shares in Q4 2021, an estimated $287K.
  • ALPS Advisors first reported a position in NeoGenomics in Q1 2020 and held it in 7 quarters.
  • ALPS Advisors's NeoGenomics position peaked at $641K in Q1 2020.
  • 307 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.

Based on ALPS Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.